Nilotinib (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth.

Similar documents
For the Patient: Ponatinib Other names: ICLUSIG

For the Patient: Olaparib tablets Other names: LYNPARZA

For the Patient: Everolimus tablets Other names: AFINITOR

For the Patient: Rituximab injection Other names: RITUXAN

Sorafenib (so-ra-fe-nib) is a drug that is used to treat many types of cancer. It is a tablet that you take by mouth.

For the Patient: Eribulin Other names: HALAVEN

For the Patient: Lenalidomide Other names: REVLIMID

For the Patient: Bendamustine Other names: TREANDA

For the Patient: Amsacrine Other names: AMSA PD

For the Patient: Cobimetinib tablets Other names: COTELLIC

For the Patient: Fludarabine injection Other names: FLUDARA

For the Patient: Mitoxantrone Other names:

For the Patient: Trastuzumab emtansine Other names: KADCYLA

For the Patient: Sunitinib Other names: SUTENT

For the Patient: UGINETEV Other Names: Treatment of advanced neuroendocrine tumours of gastrointestinal origin (Non-Functional) using Everolimus

For the Patient: Paclitaxel Other names: TAXOL

For the Patient: Cyclosporine injection Other names: SANDIMMUNE I.V.

For the Patient: PROTOCOL SMAVTMZ Other Names: Palliative Therapy for Malignant Melanoma with Brain Metastases Using Temozolomide

For the Patient: GIPAJGEM Other Names: Adjuvant chemotherapy for pancreatic cancer using Gemcitabine

For the Patient: GIPGEM Other Names: Metastatic cancer of the pancreas, gallbladder or bile duct.

For the Patient: Alemtuzumab SC injection Other names: MABCAMPATH, CAMPATH

For the Patient: LUAVPG (Carboplatin Option)

ABOUT THIS MEDICATION What is this drug used for? Gemcitabine is an intravenous anticancer medication used for some types of cancer.

For the Patient: Methotrexate Other names: MTX

For the Patient: LUAVPEM

For the Patient: LUAVPP (Carboplatin Option)

For the Patient: HNAVFUP Treatment for Advanced Squamous Cell Cancer of the Head and Neck using Fluorouracil and Platinum

For the Patient: Lenvatinib Other names: LENVIMA

For the Patient: ULUAVPMTN

For the Patient: Vemurafenib Other names: ZELBORAF

For the Patient: LUSCTOP

For the Patient: Afatinib Other names: GIOTRIF, GILOTRIF

For the Patient: Epirubicin Other names: PHARMORUBICIN

For the Patient: Doxorubicin pegylated liposomal Other names: CAELYX, DOXIL, PLD

For the Patient: LUAJPC

For the Patient: LUPUPE (Carboplatin Option)

What are these drugs used for? Paclitaxel and carboplatin are intravenous anticancer medications used for many types of cancer.

ABOUT THIS MEDICATION

For the Patient: GIAVPG Other Names: First-line palliative chemotherapy for advanced gallbladder and bile duct cancer using Gemcitabine and Cisplatin

For the Patient: GIAVPANI Other Names: Palliative third line treatment of metastatic cancer of the colon or rectum using Panitumumab

For the Patient: LUAVNP

For the Patient: Protocol LUAJNP Other names: Adjuvant Treatment of Non-Small Cell Lung Cancer with Cisplatin and Vinorelbine

ABOUT THIS MEDICATION

For the Patient: GDP-R Other names: LYGDPR

For the Patient: GIENACTRT Treatment of esophageal and gastroesophageal cancer, prior to surgery, using Carboplatin, Paclitaxel and Radiation Therapy.

For the Patient: GIA Other Names: Palliative chemotherapy for cancer of the liver (hepatoma) using Doxorubicin

For the Patient: LUAVPP

For the Patient: LUSCPE

ABOUT THIS MEDICATION What are these drugs used for? Docetaxel is an anticancer drug used to treat cancers in the area of the neck and throat.

For the Patient: LUAVPG

For the Patient: UMYLDREL

For the Patient: LUPUPE

U = Undesignated GI = GastroIntestinal AJ = Adjuvant RALOX = Raltitrexed, Oxaliplatin

For the Patient: GIPAVCAP Other Names: Second line treatment of metastatic or unresectable pancreatic adenocarcinoma using Capecitabine

For the Patient: CAP. Capecitabine. Uses:

For the Patient: GIPAJGCAP Other Names: Adjuvant chemotherapy for pancreatic adenocarcinoma using Gemcitabine and Capecitabine

For the Patient: GOOVDDCAT

For the Patient: GOOVCATM

For the Patient: GIAVTZCAP Other Names: Palliative therapy of metastatic neuroendocrine cancer of the pancreas, using Temozolomide and Capecitabine

For the Patient: GOOVCATR

For the Patient: USMAVTRA Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Trametinib

(pack li TAX ell) For treating breast cancer, lung cancer, ovarian cancer, Kaposi's sarcoma or other cancers

For the Patient: USMAVFIPI

For the Patient: GOCXCATB

For the Patient: GIAJCAPOX Other Names: Adjuvant combination chemotherapy for Stage III and IIB colon cancer using capecitabine and oxaliplatin.

ABOUT THIS MEDICATION

You are being asked to take octreotide as a treatment to manage the symptoms of your cancer.

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

For the Patient: LULAPERT

For the Patient: USMAVVC Other Names: Treatment of BRAF V600 Mutation-Positive Unresectable or Metastatic Melanoma Using Vemurafenib and Cobimetinib

For the Patient: GIRCRT Adjuvant therapy for high risk cancer of the rectum with combined Capecitabine and Radiation Therapy

Treatment Plan: Drugs:

For the Patient: GICART Other Names: Curative therapy for cancer of the anal canal using combined Mitomycin, Capecitabine and Radiation Therapy

For the Patient: USMAVNIV

For the Patient: SAAJAP

For the Patient: LUAVDC

For the Patient: ULUAVPMB

For the Patient: GIPE Palliative therapy of neuroendocrine tumours using Cisplatin and Etoposide

For the Patient: ACTW Other names: BRAJACTW

For the Patient: USMAVPEM

What are these drugs used for? Oxaliplatin, bevacizumab and capecitabine are drugs given to treat cancer of the colon or rectum.

For the Patient: Adjuvant therapy for breast cancer using weekly paclitaxel and trastuzumab (Herceptin)

= GastroIntestinal Gastric (stomach) = Advanced = Fluorouracil, Folinic Acid, OXaliplatin ABOUT THIS MEDICATION

For the Patient: LUSCCAV

Sunitinib. Other Names: Sutent. About This Drug. Possible Side Effects. Warnings and Precautions

For the Patient: Neoadjuvant therapy for locally advanced breast cancer using weekly paclitaxel followed by doxorubicin and cyclophosphamide

For the Patient: LUOTPAC

For the Patient: DC. D Docetaxel (TAXOTERE ) C Cyclophosphamide

ABOUT THIS MEDICATION

For the Patient: GUBEP

For the Patient: ACD

GI = GastroIntestinal FOLFIRI = Folinic Acid, Fluorouracil, Irinotecan

ABOUT THIS MEDICATION

ABOUT THIS MEDICATION

What are these drugs used for? Irinotecan, fluorouracil (5FU), leucovorin, and panitumumab are drugs given to treat metastatic colorectal cancer.

For the Patient: LYEPOCHR Other Names: DA-EPOCHR

(sunitinib malate) for Kidney Cancer

This therapy is being given to treat your cancer of the anal canal with the intention of cure.

Transcription:

For the Patient: Other names: TASIGNA (nil ot' i nib) is a drug that is used to treat some types of cancer. It is a capsule that you take by mouth. Blood tests may be taken regularly during treatment. The dose and timing of your nilotinib may be changed based on the test results and/or other side effects. It is important to take nilotinib exactly as directed by your doctor. Make sure you understand the directions. Take nilotinib only on an empty stomach (one hour before or two hours after food). Do NOT take with food. If you miss a dose of nilotinib, skip the missed dose and continue at the time of your next usual dosing time. Don t take any doses to make up for the missed dose. If you vomit the dose of nilotinib within 30 minutes of taking it, repeat the dose. Let your doctor know as a medication to prevent nausea may be required for future doses. Other drugs such as ketoconazole (APO-KETOCONAZOLE ), midazolam (VERSED ), rifampin (RIFADIN ), and warfarin (COUMADIN ) may interact with nilotinib. Tell your doctor if you are taking these or any other drugs as you may need extra blood tests or your dose may need to be changed. Check with your doctor or pharmacist if you are taking drugs to reduce stomach acid such as famotidine (PEPCID ) or calcium carbonate (TUMS ). Check with your doctor or pharmacist before you start or stop taking any other drugs. Avoid grapefruit and grapefruit juice for the duration of your treatment, as these may interact with nilotinib. The drinking of alcohol (in small amounts) does not appear to affect the safety or usefulness of nilotinib. may damage sperm and may harm the baby if used during pregnancy. It is best to use birth control while being treated with nilotinib. Tell your doctor right away if you or your partner becomes pregnant. Do not breast feed during treatment. Store nilotinib capsules out of the reach of children, at room temperature, away from heat, light, and moisture. BC Cancer Agency Cancer Drug Manual Page 1 of 5

Tell doctors, dentists, and other health professionals that you are being treated with nilotinib before you receive any treatment from them. Changes in blood counts may cause temporary changes in your blood counts. Your doctor will be following these changes carefully by performing blood tests. Adjustment of your treatment may be needed in certain circumstances. BLOOD COUNTS Normal white blood cells protect your body by fighting bacteria (germs) that cause infection. When they are low, you are at greater risk of having an infection. Normal platelets help your blood to clot normally after an injury (e.g., cut). When the platelet count is low, you may be more likely to bruise or bleed. To help prevent infection: Wash your hands often and always after using the bathroom. Avoid crowds and people who are sick. Call your doctor immediately at the first sign of an infection such as fever (over 100 F or 38 C by an oral thermometer), chills, cough, or burning when you pass urine. To help prevent bleeding problems: Try not to bruise, cut, or burn yourself. Clean your nose by blowing gently. Do not pick your nose. Avoid constipation. Brush your teeth gently with a soft toothbrush as your gums may bleed more easily. Some medications such as ASA (e.g., ASPIRIN ) or ibuprofen (e.g., ADVIL ) may increase your risk of bleeding. Do not stop taking any medication that has been prescribed by your doctor (e.g., ASA for your heart). For minor pain, try acetaminophen (e.g., TYLENOL ) first, but occasional use of ibuprofen may be acceptable. BC Cancer Agency Cancer Drug Manual Page 2 of 5

Side effects are listed in the following table in the order in which they may occur. Tips to help manage the side effects are included. SIDE EFFECTS Nausea and vomiting may sometimes occur. Skin reactions such as rash, and itchiness may sometimes occur. Constipation may sometimes occur. Diarrhea may sometimes occur. Headache may sometimes occur. Sugar control may rarely be affected in diabetics. You may be given a prescription for antinausea drug(s) to take before your chemotherapy treatment and/or at home. It is easier to prevent nausea than treat it once it has occurred, so follow directions closely. Drink plenty of fluids. Eat and drink often in small amounts. Make sure you are still taking your capsules on an empty stomach (one hour before or two hours after food). Try the ideas in Food Choices to Help Control Nausea.* Moisturizing creams can help reduce skin dryness. If skin reactions persist or get worse, call your doctor If itching is very irritating, call your doctor. Otherwise, be sure to mention it at your next visit. Exercise if you can. Drink plenty of fluids. Try ideas in Suggestions for Dealing with Constipation.* If diarrhea is a problem: Drink plenty of fluids. Eat and drink often in small amounts. Avoid high fibre foods as outlined in Food Ideas to Help with Diarrhea During Chemotherapy.* Note: If lactose in milk usually gives you diarrhea, the lactose in the capsule may be causing your diarrhea. Take LACTAID tablets just before your nilotinib dose. Take acetaminophen (e.g., TYLENOL ) every 4-6 hours if needed, to a maximum of 4 g (4000 mg) per day. Check your blood sugar regularly if you are diabetic. BC Cancer Agency Cancer Drug Manual Page 3 of 5

SIDE EFFECTS Fatigue (tiredness) and lack of energy may sometimes occur. Hair loss is rare with nilotinib. If you lose hair, it will grow back once you stop treatment with nilotinib. Colour and texture may change. Abnormal heart rhythm (QT prolongation) rarely occurs. Do not drive a car or operate machinery if you are feeling tired. Try the ideas in Your Bank to Energy Savings: How People with Cancer Can Handle Fatigue.* If hair loss is a problem, refer to For the Patient: Hair Loss Due to Chemotherapy.* Minimize your risk of abnormal heart rhythm by: always checking with your pharmacist and doctor about drug interactions when starting a new medication, herbal product, or supplement always taking nilotinib on an empty stomach (not with food) avoiding grapefruit and grapefruit juice *Please ask your chemotherapy nurse or pharmacist for a copy. STOP TAKING NILOTINIB AND SEE YOUR DOCTOR OR GET EMERGENCY HELP IMMEDIATELY IF YOU HAVE: Signs of an infection such as fever (over 100 F or 38 C by an oral thermometer), shaking chills; severe sore throat, productive cough (coughing up thick or green sputum); cloudy or foul smelling urine; painful, tender, or swollen red skin wounds or sores. Signs of bleeding problems such as black, tarry stools; blood in urine; pinpoint red spots on skin; extensive bruising. Signs of heart or lung problems such as fast or uneven heartbeat, chest pain, chest pressure, shortness of breath or difficulty in breathing, swelling of feet or lower legs, or fainting. SEE YOUR DOCTOR AS SOON AS POSSIBLE (DURING OFFICE HOURS) IF YOU HAVE: Signs of anemia such as unusual tiredness or weakness. Signs of liver problems such as yellow eyes or skin, white or clay-coloured stools. Numbness or tingling in feet or hands. Persistent abdominal pain. BC Cancer Agency Cancer Drug Manual Page 4 of 5

CHECK WITH YOUR DOCTOR IF ANY OF THE FOLLOWING CONTINUE OR BOTHER YOU: Uncontrolled nausea, vomiting, or diarrhea. Headache not controlled with acetaminophen (e.g., TYLENOL ). Easy bruising or minor bleeding. Skin rash or itching. For diabetics: uncontrolled blood sugars. REPORT ADDITIONAL PROBLEMS TO YOUR DOCTOR BC Cancer Agency Cancer Drug Manual Page 5 of 5